Administration of exogenous kynurenic acid decreases ischemia-reperfusion-induced AKI in mice (58), and blockade of the KP at kynurenine 3-monooxygenase with shunting toward kynurenic acid has a similar effect (29). This evidence concerns the gene KMO and acute kidney injury.